Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted Total Current Liabilities of $10.4 million for Q1 2026, down 0.56% sequentially from $10.5 million in Q4 2025, and up 6.98% YoY from $9.8 million in Q1 2025.
Analysis
Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Total Current Liabilities for 7 years, with the latest figure at $10.4 million in Q1 2026.
- Quarterly Total Current Liabilities rose 6.98% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 6.98% YoY) and the FY2025 annual result came in at $10.5 million, up 21.12% from the prior year.
- Total Current Liabilities fell to $10.4 million in Q1 2026 per DRTS's latest filing, from $10.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $10.5 million in Q4 2025 and troughed at $2.8 million in Q2 2022.
- A 5-year average of $6.9 million and a median of $6.5 million in 2024 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 95.95% in 2023, down 15.36% in 2023.
- Over 5 years, Total Current Liabilities stood at $4.3 million in 2022, then soared by 63.72% to $7.1 million in 2023, then advanced by 22.15% to $8.7 million in 2024, then climbed by 21.12% to $10.5 million in 2025, then fell by 0.56% to $10.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $10.4 million, $10.5 million, and $9.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Alpha Tau Medical | 1.21 Bn | 1.11 Bn | - | 9.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Mar 31, 2026 | 10.45 Mn |
| Dec 31, 2025 | 10.51 Mn |
| Sep 30, 2025 | 9.14 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 9.77 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | 6.46 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 6.24 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.34 Mn |
| Sep 30, 2022 | 3.35 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 6.30 Mn |
| Dec 31, 2021 | 4.41 Mn |
| Dec 31, 2020 | 2.09 Mn |